Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Ovarian Neoplasms × Interferon alpha-2 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 11 Carcinoma, Renal Cell 6 Neoplasm Metastasis 4 Leukemia 4 Triple Negative Breast Neoplasms 3 Recurrence 3 Pancreatic Neoplasms 2 Neoplasms 2 Multiple Myeloma 2 Lymphoma 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Kidney Neoplasms 2 Hematologic Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Brain Neoplasms 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Thrombocythemia, Essential 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Polycythemia Vera 1 Peritoneal Neoplasms 1 Ovarian Neoplasms 1 Ovarian Cancer Recurrent 1

Interventions

Carboplatin 139 Paclitaxel 136 Bevacizumab 88 Cyclophosphamide 56 olaparib 41 Cisplatin 41 Topotecan 39 Gemcitabine 39 niraparib 37 pembrolizumab 35 liposomal doxorubicin 35 Surveys and Questionnaires 29 Hyperthermic Intraperitoneal Chemotherapy 27 Filgrastim 26 Docetaxel 24 fludarabine 23 Blood Specimen Collection 21 Taxes 20 Drug Therapy 20 Cytoreduction Surgical Procedures 20 Peripheral Blood Stem Cell Transplantation 19 Magnetic Resonance Spectroscopy 19 Doxorubicin 19 Etoposide 18 durvalumab 16 Specimen Handling 16 Albumin-Bound Paclitaxel 15 Letrozole 13 Immunoglobulin G 13 Disulfides 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01639885 2014-01-07

CHIP

Leiden University Medical Center

Phase 1/2 Completed

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡